SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-014824
Filing Date
2022-08-04
Accepted
2022-08-04 16:46:08
Documents
95
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q bbio-20220630.htm   iXBRL 10-Q 5155518
2 EX-10.1 bbio-ex10_1.htm EX-10.1 1205888
3 EX-10.2 bbio-ex10_2.htm EX-10.2 1342512
4 EX-31.1 bbio-ex31_1.htm EX-31.1 33211
5 EX-31.2 bbio-ex31_2.htm EX-31.2 33331
6 EX-32.1 bbio-ex32_1.htm EX-32.1 15541
7 EX-32.2 bbio-ex32_2.htm EX-32.2 15854
  Complete submission text file 0000950170-22-014824.txt   21990591

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bbio-20220630.xsd EX-101.SCH 120351
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bbio-20220630_cal.xml EX-101.CAL 85218
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bbio-20220630_lab.xml EX-101.LAB 855296
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bbio-20220630_def.xml EX-101.DEF 476598
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bbio-20220630_pre.xml EX-101.PRE 655997
89 EXTRACTED XBRL INSTANCE DOCUMENT bbio-20220630_htm.xml XML 4179415
Mailing Address 421 KIPLING STREET PALO ALTO CA 94301
Business Address 421 KIPLING STREET PALO ALTO CA 94301 (650) 391-9740
BridgeBio Pharma, Inc. (Filer) CIK: 0001743881 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38959 | Film No.: 221137382
SIC: 2834 Pharmaceutical Preparations